UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 142

Sortiert nach

Statins as Anticancer Agents in the Era of Precision Medicine

Clinical cancer research, 2020-11, Vol.26 (22), p.5791-5800

2020

Volltextzugriff (PDF)

MYC protein interactors in gene transcription and cancer

Nature reviews. Cancer, 2021-09, Vol.21 (9), p.579

2021

Volltextzugriff (PDF)

Dysregulation of the mevalonate pathway promotes transformation

Proceedings of the National Academy of Sciences - PNAS, 2010-08, Vol.107 (34), p.15051-15056

2010

Volltextzugriff (PDF)

The MYC oncoprotein directly interacts with its chromatin cofactor PNUTS to recruit PP1 phosphatase

Nucleic acids research, 2022-04, Vol.50 (6), p.3505

2022

Volltextzugriff (PDF)

Rapid 3D phenotypic analysis of neurons and organoids using data-driven cell segmentation-free machine learning

PLoS computational biology, 2021-02, Vol.17 (2), p.e1008630-e1008630

2021

Volltextzugriff (PDF)

MYC dephosphorylation by the PP1/PNUTS phosphatase complex regulates chromatin binding and protein stability

Nature communications, 2018-08, Vol.9 (1), p.3502-13, Article 3502

2018

Volltextzugriff (PDF)

Lovastatin induces apoptosis of ovarian cancer cells and synergizes with doxorubicin: potential therapeutic relevance

BMC cancer, 2010-03, Vol.10 (1), p.103-103, Article 103

2010

Volltextzugriff (PDF)

The c-Myc oncogene directly induces the H19 noncoding RNA by allele-specific binding to potentiate tumorigenesis

Cancer research (Chicago, Ill.), 2006-05, Vol.66 (10), p.5330-5337

2006

Volltextzugriff (PDF)

Reflecting on 25 years with MYC

Nature reviews. Cancer, 2008-12, Vol.8 (12), p.976-990

2008

Volltextzugriff (PDF)

Computational pharmacogenomic screen identifies drugs that potentiate the anti-breast cancer activity of statins

Nature communications, 2022-10, Vol.13 (1), p.6323-6323, Article 6323

2022

Volltextzugriff (PDF)

An actionable sterol-regulated feedback loop modulates statin sensitivity in prostate cancer

Molecular metabolism (Germany), 2019-07, Vol.25, p.119-130

2019

Volltextzugriff (PDF)

Sterol-like drugs potentiate statin-triggered prostate cancer cell death by inhibiting SREBP2 nuclear translocation

Biomedicine & pharmacotherapy, 2024-08, Vol.177, p.116934, Article 116934

2024

Volltextzugriff (PDF)

Transient structure and dynamics in the disordered c-Myc transactivation domain affect Bin1 binding

Nucleic acids research, 2012-07, Vol.40 (13), p.6353

2012

Volltextzugriff (PDF)

Prognostic gene signatures for non-small-cell lung cancer

Proceedings of the National Academy of Sciences - PNAS, 2009-02, Vol.106 (8), p.2824-2828

2009

Volltextzugriff (PDF)

Cyclic AMP‐hydrolyzing phosphodiesterase inhibitors potentiate statin‐induced cancer cell death

Molecular oncology, 2020-10, Vol.14 (10), p.2533-2545

2020

Volltextzugriff (PDF)

Three-Gene Prognostic Classifier for Early-Stage Non–Small-Cell Lung Cancer

Journal of clinical oncology, 2007-12, Vol.25 (35), p.5562-5569

2007

Volltextzugriff (PDF)

The interplay between cell signalling and the mevalonate pathway in cancer

Nature reviews. Cancer, 2016-11, Vol.16 (11), p.718

2016

Volltextzugriff (PDF)

Exploiting the mevalonate pathway to distinguish statin-sensitive multiple myeloma

Blood, 2010-06, Vol.115 (23), p.4787-4797

2010

Volltextzugriff (PDF)

Cancer therapeutics: Targeting the dark side of Myc

European journal of cancer (1990), 2005-11, Vol.41 (16), p.2485-2501

2005

Volltextzugriff (PDF)

Modelling the MYC-driven normal-to-tumour switch in breast cancer

Disease models & mechanisms, 2019-07, Vol.12 (7)

2019

Volltextzugriff (PDF)

Blocking the Raf/MEK/ERK pathway sensitizes acute myelogenous leukemia cells to lovastatin-induced apoptosis

Cancer research (Chicago, Ill.), 2004-09, Vol.64 (18), p.6461-6468

2004

Volltextzugriff (PDF)

Integrin α11 regulates IGF2 expression in fibroblasts to enhance tumorigenicity of human non-small-cell lung cancer cells

Proceedings of the National Academy of Sciences - PNAS, 2007-07, Vol.104 (28), p.11754-11759

2007

Volltextzugriff (PDF)

Identification of c-MYC SUMOylation by mass spectrometry

PloS one, 2014-12, Vol.9 (12), p.e115337-e115337

2014

Volltextzugriff (PDF)

Gene Expression Profiling in Cervical Cancer: An Exploration of Intratumor Heterogeneity

Clinical cancer research, 2006-10, Vol.12 (19), p.5632-5640

2006

Volltextzugriff (PDF)

MYC Deregulation in Primary Human Cancers

Genes, 2017-05, Vol.8 (6), p.151

2017

Volltextzugriff (PDF)

1 – 25 von 142

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(135)
Mit Volltextzugriff
(129)

Publikationsform

Sprache

Englisch
(142)
Japanisch
(28)

Erscheinungsjahr

n.n

Thema

Science & Technology
(102)
Life Sciences & Biomedicine
(93)
Humans
(79)
Oncology
(47)
Animals
(36)
Biochemistry & Molecular Biology
(32)
Apoptosis
(31)
Cell Biology
(31)
Proto-Oncogene Proteins C-Myc - Metabolism
(28)
Biological And Medical Sciences
(25)
Mice
(22)
Proto-Oncogene Proteins C-Myc - Genetics
(21)
Cell Line, Tumor
(20)
Female
(20)
Tumors
(20)
Cancer
(17)
Medical Sciences
(17)
Apoptosis - Drug Effects
(15)
Myc
(15)
Proteins
(15)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Statins as Anticancer Agents in the Era of Precision Medicine

MYC protein interactors in gene transcription and cancer

Dysregulation of the mevalonate pathway promotes transformation

The MYC oncoprotein directly interacts with its chromatin cofactor PNUTS to recruit PP1 phosphatase

Rapid 3D phenotypic analysis of neurons and organoids using data-driven cell segmentation-free machine learning

MYC dephosphorylation by the PP1/PNUTS phosphatase complex regulates chromatin binding and protein stability

Lovastatin induces apoptosis of ovarian cancer cells and synergizes with doxorubicin: potential therapeutic relevance

The c-Myc oncogene directly induces the H19 noncoding RNA by allele-specific binding to potentiate tumorigenesis

Reflecting on 25 years with MYC

Computational pharmacogenomic screen identifies drugs that potentiate the anti-breast cancer activity of statins

An actionable sterol-regulated feedback loop modulates statin sensitivity in prostate cancer

Sterol-like drugs potentiate statin-triggered prostate cancer cell death by inhibiting SREBP2 nuclear translocation

Transient structure and dynamics in the disordered c-Myc transactivation domain affect Bin1 binding

Prognostic gene signatures for non-small-cell lung cancer

Cyclic AMP‐hydrolyzing phosphodiesterase inhibitors potentiate statin‐induced cancer cell death

Three-Gene Prognostic Classifier for Early-Stage Non–Small-Cell Lung Cancer

The interplay between cell signalling and the mevalonate pathway in cancer

Exploiting the mevalonate pathway to distinguish statin-sensitive multiple myeloma

Cancer therapeutics: Targeting the dark side of Myc

Modelling the MYC-driven normal-to-tumour switch in breast cancer

Blocking the Raf/MEK/ERK pathway sensitizes acute myelogenous leukemia cells to lovastatin-induced apoptosis

Integrin α11 regulates IGF2 expression in fibroblasts to enhance tumorigenicity of human non-small-cell lung cancer cells

Identification of c-MYC SUMOylation by mass spectrometry

Gene Expression Profiling in Cervical Cancer: An Exploration of Intratumor Heterogeneity

MYC Deregulation in Primary Human Cancers

Suchergebnisse filtern